Cargando…
Multifaceted Mechanisms of Action of Metformin Which Have Been Unraveled One after Another in the Long History
While there are various kinds of drugs for type 2 diabetes mellitus at present, in this review article, we focus on metformin which is an insulin sensitizer and is often used as a first-choice drug worldwide. Metformin mainly activates adenosine monophosphate-activated protein kinase (AMPK) in the l...
Autores principales: | Kaneto, Hideaki, Kimura, Tomohiko, Obata, Atsushi, Shimoda, Masashi, Kaku, Kohei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962041/ https://www.ncbi.nlm.nih.gov/pubmed/33807522 http://dx.doi.org/10.3390/ijms22052596 |
Ejemplares similares
-
Comprehensive Search for GPCR Compounds which Can Enhance MafA and/or PDX-1 Expression Levels Using a Small Molecule Compound Library
por: Kaneto, Hideaki, et al.
Publicado: (2023) -
Unexpected Pleiotropic Effects of SGLT2 Inhibitors: Pearls and Pitfalls of This Novel Antidiabetic Class
por: Kaneto, Hideaki, et al.
Publicado: (2021) -
Molecular Mechanism of Pancreatic β-Cell Failure in Type 2 Diabetes Mellitus
por: Kaneto, Hideaki, et al.
Publicado: (2022) -
Notable Underlying Mechanism for Pancreatic β-Cell Dysfunction and Atherosclerosis: Pleiotropic Roles of Incretin and Insulin Signaling
por: Kaneto, Hideaki, et al.
Publicado: (2020) -
Favorable Effects of GLP-1 Receptor Agonist against Pancreatic β-Cell Glucose Toxicity and the Development of Arteriosclerosis: “The Earlier, the Better” in Therapy with Incretin-Based Medicine
por: Kaneto, Hideaki, et al.
Publicado: (2021)